ArticleAsian Pacific journal of cancer prevention : APJCP2025
Long-Term Survival Rate for Moroccan Patients with Differentiated Thyroid Cancer.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prognosis for differentiated thyroid cancer of follicular origin (DTC) is generally good, with survival rates comparable to those of the general population for some patients. However, overall survival is influenced by many factors. Our study aims to analyze five-year and ten-year overall survival rates in follicular differentiated thyroid cancer and the independent factors influencing it in Moroccan patients.
methodsThis retrospective cohort study included all patients with differentiated thyroid cancer referred to the nuclear medicine department at Ibn Rochd Hospital between 2004 and 2012. Using the Kaplan-Meier method, we calculated overall survival, five-year survival, and ten-year survival rates. We compared overall survival according to several factors using the log-rank test.
resultsA total of 1366 patients were included in the study, distributed as follows: 89.6% were female, and 10.4% were male, with a sex ratio of 8.5. The mean age at diagnosis was 44 years, with extremes ranging from 14 to 85 years. The mean overall survival was 26.074 years [25.51; 26.63 years]. The five-year survival rate was 94%, and the ten-year survival rate was 91%. Male gender, age over 55 years, follicular histological type, tumor size >4 cm, ETE and vascular invasion, postoperative Tg level and post-RAI therapy >10 ng/ml, presence of lymph node invasion, and distant metastases are factors that reduce survival rates in patients with DTC. Additionally, advanced-stage and high-risk groups are associated with lower overall survival rates (p <0.001).
conclusionOverall survival rates in Moroccan patients with DTC are equivalent to those described in the literature. It is also significantly influenced by age, gender, histological type, vascular invasion, extra-thyroidal extension, postoperative Tg level, post-RAI therapy, the presence of lymph node invasion and distant metastases, as well as disease stage and risk group, as widely reported in the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.